← Back to Cancer ScreeningFDA approved (CRC test only)
Shield by Guardant
Adults 45+ wanting non-invasive CRC screening
$1495
Test Performance
Sensitivity
83% for CRC (54.5-65% Stage I)
Specificity
90%
Detection Method
ctDNA
Turnaround
10-14 days
Key Features
FDA-approved for CRC • Medicare coverage • Blood-based alternative to colonoscopy • Primary screening option
Who It's For
Important Notes
First FDA-approved blood test for primary colorectal cancer screening. $1,495 cash pay;most insured patients pay $0. Medicare covered, UnitedHealthcare coverage added, VA Community Care covered. ADLT status from CMS. Detects only 13% of advanced adenomas. Note:Guardant's separate Shield MCD multi-cancer test is NOT FDA approved and is a different product at a different price.
Learn more about Shield by Guardant
Discuss with your physician before ordering.
Visit Shield by GuardantCompare All